Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Hospira
>
Let the STAMPEDE TO LEAVE begin!
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 4680421"]Sumant Ramachandra, M.D., Ph.D., age 43, is Hospira's Senior Vice President, Research and Development, Medical and Regulatory Affairs and Chief Scientific Officer. Dr. Ramachandra has served in that position since July 2008. Dr. Ramachandra served as Vice President and Senior Project Leader, Global Development, at Schering-Plough, a global healthcare company, in 2007 and 2008.</p><p><br /></p><p>Compensation for 2011</p><p>Salary $489,500 </p><p>Restricted stock awards $550,000 </p><p>All other compensation $34,264 </p><p>Option awards $550,000 </p><p>Non-equity incentive plan compensation $39,160 </p><p>Total Compensation $1,662,924 </p><p><br /></p><p>Options Exercised for 2011</p><p>Number of securities underlying options exercisable 75,000 </p><p>Shares acquired on exercise 79,433 </p><p><br /></p><p>Stock Ownership for 2012</p><p>Number of shares owned 20,624[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 4680421"]Sumant Ramachandra, M.D., Ph.D., age 43, is Hospira's Senior Vice President, Research and Development, Medical and Regulatory Affairs and Chief Scientific Officer. Dr. Ramachandra has served in that position since July 2008. Dr. Ramachandra served as Vice President and Senior Project Leader, Global Development, at Schering-Plough, a global healthcare company, in 2007 and 2008. Compensation for 2011 Salary $489,500 Restricted stock awards $550,000 All other compensation $34,264 Option awards $550,000 Non-equity incentive plan compensation $39,160 Total Compensation $1,662,924 Options Exercised for 2011 Number of securities underlying options exercisable 75,000 Shares acquired on exercise 79,433 Stock Ownership for 2012 Number of shares owned 20,624[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Hospira
>
Let the STAMPEDE TO LEAVE begin!
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Hospira
>
Let the STAMPEDE TO LEAVE begin!
>